Get the Stockscreener App
2.52
0.40%
-0.010
After Hours:
2.52
Whitehawk Therapeutics Inc stock is traded at $2.52, with a volume of 58,480.
It is down -0.40% in the last 24 hours and up +1.20% over the past month.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.
See More
Previous Close:
$2.53
Open:
$2.52
24h Volume:
58,480
Relative Volume:
0.03
Market Cap:
$118.76M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.02%
1M Performance:
+1.20%
6M Performance:
+26.63%
1Y Performance:
+0.00%
1-Day Range:
$2.5049
$2.6053
1-Week Range:
$2.36
$2.6053
52-Week Range:
$1.39
$3.7699
Whitehawk Therapeutics Inc Stock (WHWK) Company Profile
Name
Whitehawk Therapeutics Inc
Sector
Industry
Phone
551-321-2234
Address
2 HEADQUARTERS PLAZA, MORRISTOWN
Compare WHWK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
WHWK
Whitehawk Therapeutics Inc
|
2.52 | 119.23M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Whitehawk Therapeutics Inc Stock (WHWK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-27-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-21-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-21-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-15-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-11-22 | Initiated | Jefferies | Buy |
| Oct-01-21 | Initiated | Cowen | Outperform |
| Sep-14-21 | Initiated | Ladenburg Thalmann | Buy |
| Sep-08-21 | Initiated | Piper Sandler | Overweight |
View All
Whitehawk Therapeutics Inc Stock (WHWK) Latest News
Whitehawk Therapeutics, Inc.Common Stock (Nasdaq:WHWK) Stock Quote - FinancialContent
Whitehawk Therapeutics (NASDAQ:WHWK) Now Covered by Jones Trading - MarketBeat
Whitehawk Therapeutics (WHWK) Receives Buy Rating from Jones Tra - GuruFocus
Jones Trading initiates coverage on Whitehawk Therapeutics stock with Buy rating - Investing.com Canada
Published on: 2025-12-21 14:50:11 - Улправда
Will Whitehawk Therapeutics Inc. stock recover faster than market2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда
Will Whitehawk Therapeutics Inc. (3350) stock test record highs in 2025July 2025 Setups & Smart Investment Allocation Tips - Улправда
Will Whitehawk Therapeutics Inc. stock maintain momentum in 2025Market Sentiment Summary & Weekly Breakout Stock Alerts - ulpravda.ru
What risks investors should watch in Whitehawk Therapeutics Inc. stockJuly 2025 Fed Impact & Community Trade Idea Sharing Platform - Улправда
Published on: 2025-12-19 20:40:41 - Улправда
Investment Recap: Will Whitehawk Therapeutics Inc. stock maintain momentum in 20252025 Short Interest & Weekly Breakout Watchlists - Улправда
Is Whitehawk Therapeutics Inc. stock a buy for dividend growthJuly 2025 EndofMonth & Long-Term Safe Return Strategies - DonanımHaber
Will Whitehawk Therapeutics Inc. stock continue upward momentum2025 Key Lessons & Advanced Swing Trade Entry Plans - DonanımHaber
Can Whitehawk Therapeutics Inc. (3350) stock double in coming yearsMarket Risk Analysis & Weekly High Conviction Ideas - DonanımHaber
Why Whitehawk Therapeutics Inc. stock remains resilientQuarterly Trade Review & Breakout Confirmation Alerts - Улправда
How interest rate cuts could boost Whitehawk Therapeutics Inc. stockOil Prices & Weekly Setup with ROI Potential - ulpravda.ru
Can Whitehawk Therapeutics Inc. stock weather global recession2025 Valuation Update & Long-Term Growth Portfolio Plans - Улправда
What macro factors could drive Whitehawk Therapeutics Inc. (3350) stock higher2025 Sector Review & Stepwise Swing Trade Plans - Улправда
Is Whitehawk Therapeutics Inc. stock a dividend growth opportunityPortfolio Return Summary & Real-Time Market Sentiment Reports - Улправда
Bond Watch: Is Whitehawk Therapeutics Inc stock a top pick in earnings seasonMarket Sentiment Review & Entry Point Strategy Guides - moha.gov.vn
Financial Comparison: Whitehawk Therapeutics (NASDAQ:WHWK) vs. BetterLife Pharma (OTCMKTS:PVOTF) - Defense World
Shorts Report: What risks investors should watch in Whitehawk Therapeutics Inc stockExit Point & Smart Investment Allocation Tips - moha.gov.vn
Will Whitehawk Therapeutics Inc. (3350) stock profit from automation waveStop Loss & Daily Stock Trend Reports - Newser
What makes Whitehawk Therapeutics Inc. stock attractive to growth fundsJuly 2025 Decliners & Low Risk High Reward Ideas - Newser
Is Whitehawk Therapeutics Inc. (3350) stock worth buying before Fed actionAnalyst Upgrade & Capital Efficient Trading Techniques - Newser
Comparing Whitehawk Therapeutics (NASDAQ:WHWK) & Acerus Pharmaceuticals (OTCMKTS:TRLPF) - Defense World
How Whitehawk Therapeutics Inc. stock performs in stagflationJuly 2025 Retail & Safe Capital Investment Plans - Newser
How Whitehawk Therapeutics Inc. stock compares to market leadersJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - Newser
Why Whitehawk Therapeutics Inc. (3350) stock stays resilientWeekly Gains Report & Expert Approved Trade Ideas - Newser
Can Whitehawk Therapeutics Inc. stock beat analyst upgradesJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Will Whitehawk Therapeutics Inc. (3350) stock benefit from commodity supercycleJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
How Whitehawk Therapeutics Inc. (3350) stock compares with top peersJuly 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
What analysts say about Whitehawk Therapeutics Inc 3350 stockValue Stock Picks & Free Stock Trading Workshops - earlytimes.in
How Whitehawk Therapeutics Inc. (3350) stock trades after earnings2025 Risk Factors & Safe Capital Growth Trade Ideas - Newser
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer - citybiz
Whitehawk therapeutics names Margaret Dugan as chief medical officer - Investing.com
Whitehawk Therapeutics appoints Margaret Dugan as chief medical officer - marketscreener.com
Whitehawk therapeutics names Margaret Dugan as chief medical officer By Investing.com - Investing.com Australia
Whitehawk Therapeutics Appoints Margaret Dugan, As Chief Medical Officer - TradingView
Published on: 2025-11-30 18:46:11 - BỘ NỘI VỤ
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference - Eastern Progress
Whitehawk Therapeutics (Nasdaq: WHWK) at Piper Sandler 37th Conference on Dec. 3 - Stock Titan
What analysts say about Whitehawk Therapeutics Inc stockSupport Level Holds & High Return Capital Gain - earlytimes.in
Is Whitehawk Therapeutics Inc. stock positioned well for digital economyWeekly Gains Report & Verified Swing Trading Watchlist - newser.com
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating By Investing.com - Investing.com Canada
Whitehawk Therapeutics stock holds steady as Jefferies maintains rating - Investing.com
Whitehawk Therapeutics Inc Stock (WHWK) Financials Data
There is no financial data for Whitehawk Therapeutics Inc (WHWK). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
2.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):